Torrent Pharma Derma Products

DERMATOLOGIC THERAPY PRODUCTS. Drug, Strength & Dosage. Mometasonefuroate 0.1%, Cream. How Torrent Pharma is integrating Unichem to boost its domestic business. The Ahmedabad-based pharma company plans to launch its first product from Bio-Pharm stable this quarter in the US; Unichem MR attrition rate has halved in the hope of a turnaround.

Torrent Pharma, the flagship company of Torrent Group, is ranked amongst the top pharma companies of India. It is a dominant player in the therapeutic areas of cardiovascular (CV) and central nervous system (CNS) and has achieved significant presence in gastro-intestinal, diabetology, anti-infective and pain management segments. It has also forayed into the therapeutic segments of nephrology and oncology while also strengthening its focus on gynecology and pediatric segments.

Right from pioneering niche marketing in India to earning the sobriquet of ‘the Company with the most first launches’, Torrent Pharma has always remained ahead of its competition. Torrent Pharma’s competitive advantage stems from its world-class manufacturing facilities, advanced R&D capabilities, extensive domestic network and a widespread global presence. It has three world-class manufacturing facilities at Indrad (Gujarat), Baddi (Himachal Pradesh) and Sikkim. The facilities are approved by USFDA, WHO, MHRA, TGA and other global regulatory bodies.

A new facility is taking shape at Dahej SEZ in Western India, which will cater to the international markets. Torrent Pharma is the sole manufacturer of Insulin Formulations for Novo Nordisk in India since the early ‘90s and has also set up a dedicated formulation and packaging facility for Insulin. Source: Torrent Pharmaceuticals Ltd: Leader in the pharmaceutical industry 2015 Torrent Pharma recognized as the Most Promising Company of the Year at the 10th CNBC TV18 India Business Leader Awards 2014. 2014 Acquired Elder Pharma’s Indentified Indian Branded Formulation Business in India and Nepal. 2011 Forayed into oncology segment. 2006 The API and formulations manufacturing facilities located at Indrad (Gujarat, India) got USFDA approval.

Detskij kostyum pozharnika svoimi rukami. 2000 Torrent Pharma bagged the Gold Trophy for IDMA Quality Excellence Award for its Formulations facility. Updated: January, 2015. • • • • • • • • • • • • • • • • • • • • • • Copyright © 2010-2019 India Brand Equity Foundation All material, information, data, images or content on this website is subject to copyright or other applicable intellectual property laws and no part of it can be reproduced in any form (including paper or electronic form) without prior written consent and approval from IBEF.

Infringements are subject to prosecution under the applicable laws. For consent related queries and conditions, please write to An initiative of the.

All information provided on this web site (www.OddwayInternational.com) property of 'Oddway International' is provided for information purposes only and does not constitute a legal contract between this site and any person or entity unless otherwise specified. Information on this site is subject to change without prior notice. Although every reasonable effort is made to present current and accurate information, the site makes no guarantees of any kind. The web site may contain information (including but not limited to medical content, images, videos, blogs and news articles) that is created and maintained by a variety of sources both internal and external to it. These internal urls / sites are unmoderated forums containing the personal opinions and other expressions of the persons who post the content / entries.